LGVN News and Press, Longeveron Inc.

MIAMI, July 19, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today ann...

2024-07-18 14:15:06 ET More on Longeveron Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript Longeveron stock rallies 19% on Alzheimer's drug update Longeveron surges on key FDA designation for Alzheimer’s drug Seeking Alpha’s Quant Rating ...

A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...

MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today ann...

2024-07-17 12:15:33 ET More on Longeveron Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript Longeveron surges on key FDA designation for Alzheimer’s drug Longeveron announces exercise of warrants for $4.4M gross proceeds Seeking Alpha’s Qu...

A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...

– FDA designation enables expedited clinical development and regulatory review timelines for Lomecel-B™ – – Second designation received for Lomecel-B™ for the treatment of mild Alzheimer’s Disease after Regenerative Medicine Advanced Thera...

2024-07-11 06:19:00 ET 3 Tips to Use When Investing in Penny Stocks in Emerging Markets Investing in penny stocks in emerging markets presents a unique opportunity for investors seeking significant returns. The key to successfully navigating this high-potential landscape lies in underst...

A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...

2024-07-10 11:38:21 ET Longeveron Inc (NASDAQ: LGVN) soared 100% on Wednesday after its Lomecel-B received RMAT designation from the Food & Drug Administration. Lomecel-B is the company’s investigational treatment for Alzheimer’s disease. Longeveron stock is st...